PET/CT in the imaging of ovarian Cancer

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review

Owen J. O’Connor¹, Priyanka Prakash², Carmel G. Cronin¹, Shaunagh McDermott¹, Michael A. Blake^1,*

Show Less

¹ Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA

² Department of Radiology, University of Pennsylvania, 3400 Spruce St., Philadelphia, PA, USA

*Author to whom correspondence should be addressed.

Academic Editor: Indrajit Chowdhury

Front. Biosci. (Elite Ed) 2013, 5(1), 141–153; https://doi.org/10.2741/E603

Published: 1 January 2013

(This article belongs to the Special Issue Applications of lentiviral vectors in molecular imaging)

Download PDF

Cite

Abstract

Ovarian cancer is responsible for the largest proportion of deaths among patients with gynecologic cancer. This paper discusses fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in the imaging of ovarian cancer. We discuss and demonstrate how FDG PET/CT can be used to appropriately guide clinical management decisions in patients with ovarian cancer. In particular, FDG PET/CT shows great promise for the preoperative evaluation of women with primary ovarian cancer and for subsequent postoperative assessment for recurrence.

Keywords

Ovarian cancer

PET-CT

Oncology

FDG- PET

Review

Previous article in this issue

Next article in this issue

Front. Biosci. (Elite Ed) Print ISSN 1945-0494 Electronic ISSN 1945-0508